跳至主要内容
临床试验/NCT05022420
NCT05022420终止不适用

SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases

University Hospital, Brest16 个研究点 分布在 1 个国家目标入组 505 人开始时间: 2021年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
505
试验地点
16
主要终点
tolerance of each type of biopsy

研究概览

简要总结

Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.

详细描述

patinets that benefited of arterial temporal biospy or salivary gland biospy or muscuar biopsy or neuro muscular biospy for his auto -mmune disease will be included and fill standardized questionnaires concerning tolerance, information and side effect at inclusion , day 7 and day 30 after the biopsy data will be analysed to evaluate information, tolerance and risk factor af side effect

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • biospy required for the diagnsis or follow up aged of more than 18 non opposition form

排除标准

  • unable to consent demencia unable to fill the form and questionnaire patient Under juridical protection refusing to participate

结局指标

主要结局

tolerance of each type of biopsy

时间窗: tolerance at day 7 after the biospy was performed

tolerance based on a standardized patient 's questionnaire

次要结局

  • tolerance of each type of biopsy 30 days after(tolerance at day 30 and at inclusion after the biospy was performed)
  • evaluation of the qualitiy of patient's information at inclusion(questionnaire at inclusion)
  • risk factor of sied effect of each biospy(standardized questionnaire at inclusion, day 7 and 30)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验

SAfety and TOlerance of the Biopsies in Auto-immune... | 临床试验